Brighton and Hove CCG and GSK Respiratory Pharmacy Joint Working Project

Executive Summary

Brighton & Hove Clinical Commissioning Group (the CCG) and GlaxoSmithKline (GSK) Joint Working project aims to support the delivery of improved patient adherence, medicines optimisation and reductions in medicines wastage, by rolling out the “Complete The Cycle” inhaler recycling scheme to pharmacies in the CCG and through training and up skilling pharmacists involved in this project.

Executive Summary

Brighton & Hove Clinical Commissioning Group (the CCG) and GlaxoSmithKline (GSK) Joint Working project aims to support the delivery of improved patient adherence,  medicines optimisation  and reductions in medicines wastage, by rolling out the “Complete The Cycle” inhaler recycling scheme to pharmacies in the CCG and through training and up skilling  pharmacists involved in this project.

This will involve measuring the levels of remaining medicine in the returned inhalers and provision of high quality targeted Medicine Use Reviews( MUR)/ Inhaler technique training in order to understand and act on poor adherence to, or inappropriate management of, asthma and COPD patients. The project will start in March 2015 and finish in May 2016

Within the project, the key objectives are:

  • To provide hard to reach respiratory patients, who currently do not participate in medication reviews, with an opportunity for referral to a pharmacist for an MUR with the aim of improving inhaler technique and providing education on  medication concordance e.g. inhaler technique assessment, discussion of medication use and self management of their respiratory disease.
  • To collect, quantify and characterise  the type and level of unused/partially used/used inhalers in the CCG to enable a  better understanding of the pattern of inhaler wastage and to be able to identify specific trends and anomalies across localities and/or classes of inhaler which may require a further intervention by the pharmacist
  • Increase community pharmacy teams’ knowledge and understanding of the management of respiratory disease and the place and use of associated medicines in respiratory disease treatment. This will enable the delivery of efficient MURs to support patients in the self management of their disease.

The benefits of the project:

The Patient

  • Provides a specific opportunity for patients to consult with a Health Care Professional. This may be their only interaction if they do not see their GP
  • Improved level of care in a pharmacy setting with the aim of improving patient’s understanding of the importance of adherence and knowledge of how to use inhalers appropriately
  • Improved patient knowledge and understanding of their respiratory condition enabling greater self management of their disease where appropriate

The NHS – Brighton & Hove CCG

  • An opportunity to provide enhanced clinical review skills and additional educational support of community pharmacists to help educate patients on managing their respiratory condition effectively
  • An increased opportunity to review patients who overuse short acting bronchodilators
  • Provide an opportunity to fulfil the CCG’s sustainability agenda and offer an opportunity to provide carbon savings

GSK

  • Improved adherence in general may lead to improved adherence to inhaled medications including GSK inhalers
  • Increased number of MURs  may increase the appropriate uptake of prescribed medicines, including GSK inhalers
  • Project will contribute to GSK’s Environmental Target of zero waste to landfill by 2020

For further information please contact the GSK UK Customer contact centre on 0800 221411

“The Complete the Cycle swirl and name is a registered trademark of the GlaxoSmithKline group of companies. This service has been fully funded by GlaxoSmithKline”

 

UK/RESP/0093/15a - Archived 2017